Zobrazeno 1 - 10
of 162
pro vyhledávání: '"Chris M Kozma"'
Publikováno v:
American Journal of Gastroenterology. 115:S386-S389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::876c3b053133e046ba56f4fa18821df4
https://doi.org/10.14309/01.ajg.0000705096.72676.b5
https://doi.org/10.14309/01.ajg.0000705096.72676.b5
Publikováno v:
Journal of drugs in dermatology : JDD. 20(10)
Guselkumab is approved by the Food and Drug Administration for the treatment of moderate-to-severe plaque psoriasis. However, characteristics of patients initiating guselkumab in a real-world setting are not well characterized. The present study desc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f91f77af1c02bc6b273cb18e55610906
https://pubmed.ncbi.nlm.nih.gov/34636519
https://pubmed.ncbi.nlm.nih.gov/34636519
Publikováno v:
Drugs-Real World Outcomes
Background Real-world evidence for how US Crohn’s disease (CD) patients use ustekinumab is limited. Objectives The aim of this study was to describe the persistence, maintenance dosing, and pre-post corticosteroid and opioid use for CD patients in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d9c41c32a2dd207d6b0388d6c3ee7ed
https://pubmed.ncbi.nlm.nih.gov/34136998
https://pubmed.ncbi.nlm.nih.gov/34136998
Publikováno v:
Obstetrics & Gynecology. 135:22S-23S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::566c5d627f043eca873bf7c75106ddf2
https://doi.org/10.1097/01.aog.0000663148.21712.70
https://doi.org/10.1097/01.aog.0000663148.21712.70
Publikováno v:
Gastroenterology. 158:S-959
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0590e9a912e8f75948a707043b808f96
https://doi.org/10.1016/s0016-5085(20)33075-4
https://doi.org/10.1016/s0016-5085(20)33075-4
Autor:
Michelle L. Rand, Terra Slaton, Adam D. Porath, Sharon Clodfelter, Brahim Bookhart, Michael J. Bloch, Chris M. Kozma
Publikováno v:
Clinical therapeutics. 41(2)
Renown Health (Reno, Nevada), a large, locally owned, not-for-profit integrated health care network, has developed an institution-wide policy to shift the treatment of deep vein thrombosis (DVT) from a short-acting anticoagulant and vitamin K antagon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5e29b7a923dbf96b24e31b4ee1f8f10
https://pubmed.ncbi.nlm.nih.gov/30642614
https://pubmed.ncbi.nlm.nih.gov/30642614
Publikováno v:
Journal of Medical Economics. 18:704-710
To explore the effect of age and sex on cost of all-cause and multiple sclerosis (MS)-related inpatient facility encounters.Adult patients with an initial MS diagnosis were identified from a national managed-care database (IMS LifeLink Health Plans D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc8cfc90cb0182d62fa66fd75b6f7b5c
https://doi.org/10.3111/13696998.2015.1044995
https://doi.org/10.3111/13696998.2015.1044995
Publikováno v:
Journal of Medical Economics. 17:872-880
The objective for the research was to evaluate the direct healthcare costs for Crohn's disease (CD) patients categorized by adherence status.Adult patients with ≥1 claim for infliximab and ≥2 claims for CD who were continuously insured for 12 mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b97d80e964b9b04f57e68f45f0dbbe6a
https://doi.org/10.3111/13696998.2014.950669
https://doi.org/10.3111/13696998.2014.950669
Publikováno v:
Journal of Managed Care Pharmacy. 20:800-807
Patients with multiple sclerosis (MS) who are adherent to their treatment regimens are less likely to experience relapses and the cost associated with relapse. Pharmacists whose practice involves these specialty pharmaceuticals used to treat MS are s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b4f06d5a8377965782cb8ff4b00dc0
https://doi.org/10.18553/jmcp.2014.20.8.800
https://doi.org/10.18553/jmcp.2014.20.8.800
Publikováno v:
Journal of Managed Care Pharmacy. 20:455-466
Approaches to pain management are diverse, requiring prescribers to evaluate an array of clinical issues and potential solutions. In addition to the difficult task of selecting a treatment option, pain treatment may be further complicated by multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c667a5b09ef66cf3824865200688cdc
https://doi.org/10.18553/jmcp.2014.20.5.455
https://doi.org/10.18553/jmcp.2014.20.5.455